1) Muller O, Garenne M, Reitmaier P, Van Zweeden AB, Kouyate B, Becher H. Effect of zinc supplementation on growth in West African children: a randomized double-blind placebo-controlled trial in rural Burkina Faso. Int J Epidemiol. 2003 ;32: 1098-102 . Abstract.

2) Garenne M. Sex differences in health indicators among children in African DHS surveys. J Biosoc Sci. 2003 35: 601-14. Abstract.

3) Muller O, Garenne M, Kouyate B, Becher H. The association between protein-energy malnutrition, malaria morbidity and all-cause mortality in West African children. Trop Med Int Health. 2003 Jun; 8(6): 507-11. Abstract.a

4) Vray M, Meynard JL, Dalban C, Morand-Joubert L, Clavel F, Brun-Vézinet F, Peytavin G, Costagliola D and Girard PM, for the Narval Trial Group Predictors of the virologic response to a change in the antiretroviral treatment regimen in HIV-1-infected patients enrolled in a randomized trial comparing genotyping, phenotyping and standard of care (Narval trial, ANRS 088) (Antiviral Therapy, 2003; 8:1-198). Abstract.

5) Brun-Vézinet F, Descamps D, Ruffaut A, Masquelier B, Calvez V, Peyatavin G, Telles F, Morand-Joubert L, Meynaud JL, Vray M, Costaglioma D; Narval (ANRS 088) Study Group. Clinically relevant interpretation of genotype for resistance to abacavir. (AIDS 2003, 17:1975-802). Abstract.

6) El Hasnaoui A, Vray M, Richard A, Nachit-Ouinekh F, Boureau F; MIGSEV Group. Assessing the severity of migraine: development of the MIGSEV scale. (Headache, 2003 43: 628-35). Abstract.

7) Landman R, Schiemann R, Thiam S, Vray M, Canestri A, Mboup S, Kane CT, Delaporte E, Sow PS, Faye MA, Gueye M, Peytavin G, Dalban C, Girard PM, Ndoye I; IMEA 011/ANRS 12-04 Study Group. Once-a-day highly active antiretroviral therapy in treatment-naïve HIV-1-infected adults in Senegal. (AIDS 2003; 1017 -22) . Abstract.

8) Garenne M, Hohmann S. (2003). A wealth index to screen high risk families: application to Morocco. Journal of Health, Population and Nutrition; 21(3):235-242 . Absctract.

9) van Asten LC, Boufassa F, Schiffer V, Brettle RP, Robertson JR, Hernandez Aguado I, McMenamin J, Zangerle R, Fontanet A, Coutinho RA, Prins M. Limited effect of highly active antiretroviral therapy among HIV-positive injecting drug users on the population level. Eur J Public Health. 2003;3:347-9. Abstract.

10) Pollakis G, Abebe A, Kliphuis A, De Wit TF, Fisseha B, Tegbaru B, Tesfaye G, Negassa H, Mengistu Y, Fontanet A, Cornelissen M, Goudsmit J. Recombination of HIV type 1C (C'/C") in Ethiopia: possible link of EthHIV-1C' to subtype C sequences from the high-prevalence epidemics in India and Southern Africa. AIDS Res Hum Retroviruses. 2003;19:999-1008. Abstract.

11) Tsegaye A, Wolday D, Otto S, Petros B, Assefa T, Alebachew T, Hailu E, Adugna F, Measho W, Dorigo W, Fontanet A, Baarle D, Miedema F. Immunophenotyping of blood lymphocytes at birth, during childhood, and during adulthood in HIV-1-uninfected Ethiopians. Clin Immunol. 2003;109:338-46. Abstract.

12) Nacher M, Singhasivanon P, Treeprasertsuk S, Silamchamroon U, Phumratanaprapin W, Fontanet A, Looareesuwan S. Gender differences in the prevalences of human infection with intestinal helminths on the Thai-Burmese border. Ann Trop Med Parasitol. 2003, 97:433-5. Abstract.

13) Truong Lien X, Luong TT, Scott-Algara D, Versmisse P, David A, Perez-Bercoff D, Nguyen NV, Tran HK, Cao CT, Fontanet A, Follézou JY, Theodorou I, Barré-Sinoussi F, Pancino G. CD4 cell and CD8 cell-mediated resistance to HIV-1 infection in exposed uninfected intravascular drug users in Vietnam. AIDS 2003,17:1425-34. Abstract.

14) van Asten L, Langendam M, Zangerle R, Hernández Aguado I, Boufassa F, Schiffer V, Brettle RP, Robertson JR, Fontanet A, Coutinho RA, Prins M. Tuberculosis risk varies with the duration of HIV infection: A prospective study of European drug users with known date of HIV seroconversion. AIDS 2003 ;17:1201-8. Abstract.

15) Mekonnen Y, Dukers NHTM, Sanders E, Dorigo W, Wolday D, Schaap A, Geskus RB, Coutinho RA, Fontanet A. Simple markers for initiating antiretroviral therapy among HIV-infected Ethiopians. AIDS, 2003;17:815-9 . Abstract.

16) Kassu A, Tsegaye A, Wolday D, Petros B, Aklilu M, Sanders E, Fontanet A, van Baarle D, Hamann D, Rinke de Wit TF. Role of incident and/or cured intestinal parasitic infections on profile of CD4+ and CD8+ T-cell subsets and activation status in HIV-1 infected and uninfected adult Ethiopians. Clinical and Experimental Immunology, 2003;132:113-9. Abstract.

17) Wolday D, Hailu B, Girma M, Hailu E, Sanders E, Fontanet A. Low CD4+T-cell and high viral load precede development of tuberculosis disease in a cohort of HIV-positive Ethiopians. The International Journal of Tuberculosis and Lung Disease, 2003;7:110-6 . Abstract.

18) Mekonnen Y, Sanders E, Aklilu M, Tsegaye A, Rinke de Wit TF, Schaap A, Wolday D, Geskus R, Coutinho RA, Fontanet A. Evidence of changes in sexual behaviours among male factory workers in Ethiopia. AIDS, 2003;17:1-9. Abstract.

Mis à jour le 12/06/2014


Unité d'Epidémiologie des Maladies Emergentes

Institut Pasteur
25-28 rue du Dr Roux
75724 Paris Cedex 15

Tél : +33 (0)1 40 61 37 66
Fax: +33 (0)1 45 68 88 76

Où nous trouver ?